Presently, more than 40 Aptamer-based drug candidates are being investigated across different phases of development for the treatment of a myriad of disease indications.
The aptamers market size is estimated to be worth $451 million in 2024 and is expected to reach $12,782 million by 2035, growing at CAGR of 36% during the forecast period, till 2035.
During our research, we were able to...
Russian 
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Romaian
Portuguese (Brazil)
Greek